Results 201 to 210 of about 42,463 (228)

Secondary Hyperparathyroidism

2016
Palak Choksi, Bradley R. Lawson
openaire   +2 more sources

Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis

Lancet, The, 2020
Mauro Chiarito, Francesco Cannata, Davide Cao   +2 more
exaly  

Fungal secondary metabolism: regulation, function and drug discovery

Nature Reviews Microbiology, 2018
Nancy P Keller
exaly  

Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric Assessment

Ca-A Cancer Journal for Clinicians, 2010
Sumanta K Pal, Vani Katheria, Arti Hurria   +2 more
exaly  

Fungal secondary metabolism — from biochemistry to genomics

Nature Reviews Microbiology, 2005
Nancy P Keller
exaly  

Regulation of fungal secondary metabolism

Nature Reviews Microbiology, 2012
Axel A Brakhage
exaly  

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Lancet, The, 2011
Salim Yusuf, Shofiqul Islam, Sumathy Rangarajan   +2 more
exaly  

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2014
Nadine Schuerer, David MacManus, Charles R M Bangham   +2 more
exaly  

[Secondary hyperparathyroidism].

Arztliche Wochenschrift, 2000
F, SCHMID, H, KIEFER
openaire   +1 more source

Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth

Lancet, The, 2008
Roberto Romero, Robert L Goldenberg
exaly